FDA Publishes Guidance on Food Derived from Genome Edited New Plant Varieties

On February 22, the FDA issued a guidance for industry that describes how firms can voluntarily engage with the FDA before marketing food from genome edited plants. The guidance reaffirms that the risk-based approach the FDA has taken for foods derived from new plant varieties also applies to foods from genome edited plants. For more information on the guidance, click here.